Concepedia

Vani Vannappagari

VV

Statistics

Publications

32

Citations

1.1K

H-Index

19

Active since

2003

Affiliations

University of North Carolina at Chapel Hill(Current)

GlaxoSmithKline (United Kingdom)

ViiV Healthcare (United Kingdom)

GlaxoSmithKline (United States)

Triangle

Vani Vannappagari is an author at University of North Carolina at Chapel Hill specializing in medicine, public health, and epidemiology.

ORCID

Top concepts

Publications per year

2003–2024

32

Publications

32

Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study

William A. Blumentals, Andres Gomez‐Caminero, Sung Joo et al. · International Journal of Impotence Research · 2004 · 148 citations

, , +9

Psychiatric Symptoms in Patients Receiving Dolutegravir

Anna Fettiplace, Chris Stainsby, Alan Winston et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2016 · 99 citations · Full text

Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case–control study of African Americans and whites

Robert C. Millikan, Jon Player, Allan René de Cotret et al. · Breast Cancer Research · 2004 · 82 citations · Full text

Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era

Stephanie A. Ruderman, Heidi M. Crane, Robin M. Nance et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 78 citations · Full text

Is erectile dysfunction predictive of peripheral vascular disease?

William A. Blumentals, Andres Gomez‐Caminero, Sung Joo et al. · The Aging Male · 2003 · 68 citations · Full text

, , +19

1–5 of 32